<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
 xmlns:blogChannel="http://backend.userland.com/blogChannelModule"
>

<channel>
<title>Keyword: mab3a6</title>
<link>https://freerepublic.com/tag/mab3a6/</link>
<description></description>
<language>en-us</language>
<lastBuildDate>Fri, 25 Apr 2025 01:04:43 GMT</lastBuildDate>
<generator>Focus Forum</generator>
<ttl>15</ttl>

<item>
<title>The Antibody From a Survivor That Outsmarts Ebola &#x26;#x2013; With a Tiny Dose</title>
<link>https://freerepublic.com/focus/f-chat/4313077/posts</link>
<description>An antibody from an Ebola survivor may be the key to fighting the virus more efficiently. The mAb 3A6 antibody binds to a hidden part of Ebola&#x26;#x2019;s structure, stopping infection in its tracks, even at record-low doses. Credit: SciTechDaily.com A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections. Sourced from a survivor of the devastating 2014&#x26;#x2013;2016 outbreak, this antibody binds to a key structure on the virus known as the &#x26;#x201C;stalk,&#x26;#x201D; effectively neutralizing it. Notably, mAb 3A6 provides potent protection even at ultra-low doses, making it cost-effective and easier...</description>
<author>Scitech Daily</author>
<comments>https://freerepublic.com/focus/f-chat/4313077/posts#comment</comments>
<pubDate>Fri, 25 Apr 2025 01:04:43 GMT</pubDate>
</item>
</channel>
</rss>